292 related articles for article (PubMed ID: 36875711)
1. Microglia as a cellular target of diclofenac therapy in Alzheimer's disease.
Stopschinski BE; Weideman RA; McMahan D; Jacob DA; Little BB; Chiang HS; Saez Calveras N; Stuve O
Ther Adv Neurol Disord; 2023; 16():17562864231156674. PubMed ID: 36875711
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
Zhang Y; Zhao Y; Zhang J; Yang G
Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect.
Miguel-Álvarez M; Santos-Lozano A; Sanchis-Gomar F; Fiuza-Luces C; Pareja-Galeano H; Garatachea N; Lucia A
Drugs Aging; 2015 Feb; 32(2):139-47. PubMed ID: 25644018
[TBL] [Abstract][Full Text] [Related]
4. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
5. The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2004 Nov; 13(11):1469-81. PubMed ID: 15500394
[TBL] [Abstract][Full Text] [Related]
6. Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populations.
Stuve O; Weideman RA; McMahan DM; Jacob DA; Little BB
Ther Adv Neurol Disord; 2020; 13():1756286420935676. PubMed ID: 32647537
[TBL] [Abstract][Full Text] [Related]
7. A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer's disease.
Yang Z; Liu J; Wei S; Deng J; Feng X; Liu S; Liu M
Front Pharmacol; 2022; 13():1077222. PubMed ID: 36699095
[TBL] [Abstract][Full Text] [Related]
8. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile.
Agdeppa ED; Kepe V; Petri A; Satyamurthy N; Liu J; Huang SC; Small GW; Cole GM; Barrio JR
Neuroscience; 2003; 117(3):723-30. PubMed ID: 12617976
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease.
Jha D; Bakker ENTP; Kumar R
J Neurochem; 2023 Feb; ():. PubMed ID: 36802053
[TBL] [Abstract][Full Text] [Related]
10. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory process in Alzheimer's Disease.
Meraz-Ríos MA; Toral-Rios D; Franco-Bocanegra D; Villeda-Hernández J; Campos-Peña V
Front Integr Neurosci; 2013; 7():59. PubMed ID: 23964211
[TBL] [Abstract][Full Text] [Related]
12. Microglia in Alzheimer's Disease: A Target for Therapeutic Intervention.
Zhang G; Wang Z; Hu H; Zhao M; Sun L
Front Cell Neurosci; 2021; 15():749587. PubMed ID: 34899188
[TBL] [Abstract][Full Text] [Related]
13. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
14. The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease.
Hanslik KL; Ulland TK
Front Neurol; 2020; 11():570711. PubMed ID: 33071950
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammatory responses in Alzheimer's disease.
Dansokho C; Heneka MT
J Neural Transm (Vienna); 2018 May; 125(5):771-779. PubMed ID: 29273951
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
Halliday G; Robinson SR; Shepherd C; Kril J
Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation in Alzheimer's disease.
Zhang F; Jiang L
Neuropsychiatr Dis Treat; 2015; 11():243-56. PubMed ID: 25673992
[TBL] [Abstract][Full Text] [Related]
19. Innate immune activation in Alzheimer's disease.
Wang MM; Miao D; Cao XP; Tan L; Tan L
Ann Transl Med; 2018 May; 6(10):177. PubMed ID: 29951499
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Hirohata M; Ono K; Naiki H; Yamada M
Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
